Description
Prevtec Microbia is developing new alternative antibiotic technologies for animal health. This project aims to demonstrate the commercial viability of a new product under development by optimizing its manufacturing process. Activities will …
Amendment chain · 4 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $72,800 at start, $72,800 after amendment #5 (+$0).
- #12018-10-31$72,800
- #32019-02-27$72,800
- #42019-06-03$72,800
- #52019-06-05$72,800
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2018-10-31 | $72,800 | — | IRAP - Technical feasibility study for the production of a pig vaccine |
| #3 amendment | 2019-02-27 | $72,800 | +$0 | Prevtec Microbia is developing new alternative antibiotic technologies for animal health. This project aims to… |
| #4 amendment | 2019-06-03 | $72,800 | +$0 | Prevtec Microbia is developing new alternative antibiotic technologies for animal health. This project aims to… |
| #5 amendment | 2019-06-05 | $72,800 | +$0 | Prevtec Microbia is developing new alternative antibiotic technologies for animal health. This project aims to… |
Related records · 5
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2025-2026-Q2-1034675 | Mediphage Bioceuticals, Inc. | FY2027 | $63,380 | FY2027 |
| 172-2025-2026-Q3-1037522 | OBKIO INC. | FY2026 | $50,000 | FY2026 |
| 172-2025-2026-Q3-1037889 | SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INC | FY2026 | $25,000 | FY2026 |
| 172-2025-2026-Q2-1034040 | Griffith Foods Limited | FY2026 | $54,880 | FY2026 |
| 172-2025-2026-Q3-1037273 | Apollo Machine & Welding Ltd. | FY2026 | $230,000 | FY2026 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2018-2019-Q3-913541 · retrieved 2026-11-12.